Tris Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Tris Pharma's estimated annual revenue is currently $116.5M per year.
- Tris Pharma's estimated revenue per employee is $281,400
- Tris Pharma's total funding is $125M.
Employee Data
- Tris Pharma has 414 Employees.
- Tris Pharma grew their employee count by 5% last year.
Tris Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Sales Force Training and Sales Force Effectiveness | Reveal Email/Phone |
2 | VP, Engineering & Facilities | Reveal Email/Phone |
3 | Head IT | Reveal Email/Phone |
4 | VP, Research & Development | Reveal Email/Phone |
5 | VP, Quality & Compliance | Reveal Email/Phone |
6 | VP Supply Chain | Reveal Email/Phone |
7 | SVP, Regulatory Affairs | Reveal Email/Phone |
8 | VP Sales | Reveal Email/Phone |
9 | Head Operations | Reveal Email/Phone |
10 | Head MSLs | Reveal Email/Phone |
Tris Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Tris Pharma?
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies. Our mission is to understand the science of developing drug products with unique attributes, bring to market products that add value to our patients and customers, and provide a benefit to our company, employees and society at large.
keywords:N/A$125M
Total Funding
414
Number of Employees
$116.5M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tris Pharma News
Perrigo Company, Vernalis, Tris Pharma, Pfizer, Acella Pharmaceuticals, GlaxoSmithKline. This comprehensive Cough Suppressant Drugs Market report helps in...
... NEOS Therapeutics, Rhodes Pharmaceuticals, Noven Therapeutics, Ironshore Pharmaceuticals, Lannett Company, Novartis, Teva, Tris Pharma,...
... Mylan Pharmaceuticals, Corium International, Mayne Pharma, Advanz Pharma ... Shionogi Pharma, Tris Pharma, Par Pharmaceutical, X Gen Pharmaceuticals,...
Deerfield provided $125m to refinance existing debt and provide growth capital to Tris Pharma, Inc., a Monmouth Junction, NJ-based fully integrated pharmaceutical company. The company intends to use the funds to expand its branded pharmaceutical portfolio with a particular focus on Attention De ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35M | 452 | 6% | N/A |
#2 | $149M | 662 | 2% | N/A |